Skip over navigation

PatientsLikeMe ™

Join Now! (It’s free)

Already a member? Sign in

  • Patients
  • Treatments
  • Symptoms
  • (You Are Here)Research
  • FAQ
Home > Research > Clinical Trials > Clinical Trial Number NCT01115270
Research
Clinical Trials
Research Tools
Public Research and Presentations
Publications from Our Team
Publications that feature PatientsLikeMe
R&D Policy
Suggestion_box Suggestions? Let us know

A Study Comparing Shunt Placement Versus Endoscopic Third Ventriculostomy in the Treatment of Hydrocephalus

Conditions Phase Intervention Type
  • Normal Pressure Hydrocephalus
  • Hydrocephalus
N/A
Other
Non-invasive measures

View trial NCT01115270 on www.clinicaltrials.gov

22 PatientsLikeMe members may be eligible for this trial.

  • Show contact details

Contacts

Please use the information below to contact the trial coordinators.

    Marvin Bergsneider, M.D.
    310-206-4100
    MBergsneider@mednet.ucla.edu Adrian Ibarra
    310-206-4100
    AIbarra@mednet.ucla.edu
×

Eligibility

Ages Eligible for Study
40 years and up
Genders Eligible for Study
Both

Keywords

Normal Pressure Hydrocephalus

Sponsors

Other
University of California, Los Angeles
Other
NIH/National Insitute of Neurological Disorders & Stroke

Inclusion Criteria

- Findings of gait/balance disturbance must be present, plus at least one other area of
impairment in cognition, urinary symptoms or both

- Minimum duration of symptoms of at least three months, progression over time, and no
other neurological, psychiatric or general medical conditions that are sufficient to
explain the presenting symptoms

- MRI or CT performed after onset of symptoms must show evidence of ventricular
enlargement (Evan's index > 0.3) not entirely attributable to cerebral atrophy or
congenital enlargement

- Criteria for shunt placement: we place greatest emphasis on the results of the
temporary CSF drainage trial. Patients who experience a temporary improvement in
neurological function (gait, bladder control, and/or cognition) are offered a shunt
operation. For patients in whom the CSF drainage results were equivocal, then other
factors such as elevated baseline ICP and/or high Rout will also be considered for a
shunt under these circumstances

Exclusion Criteria

- Age < 40

- Fixed musculoskeletal deformities that will exclude gait improvement

- Advanced dementia

- Inability to obtain an MRI study

- General medical conditions in which operative risks are excessive

- Patients taking Warfarin (Coumadin) will be excluded

Detailed Description

The main purpose of this study is to compare two types of treatment of hydrocephalus: placement of a ventriculoperitoneal (VP) shunt versus an endoscopic third ventriculostomy (ETV). A second goal of this study will be to understand how the two different types of procedures, VP shunt versus ETV, affect brain blood flow and pressures. Understanding these changes is important because the investigators hope is to someday be able to predict who will better respond to one procedure or another.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01115270

Overall Contact

Adrian Ibarra
310-206-4100
AIbarra@mednet.ucla.edu

Overall Contact Backup

Marvin Bergsneider, M.D.
310-206-4100
MBergsneider@mednet.ucla.edu

Locations

  • UCLA Neurosurgery
    Los Angeles, California United States
    (Recruiting)

    Contact info

    Adrian Ibarra
    310-206-4100
    AIbarra@mednet.ucla.edu Marvin Bergsneider, M.D.
    310-206-4100
    MBergsneider@mednet.ucla.edu

Learn more at ClinicalTrials.gov

◄ Back to list of trials

Company Info:
About Us
Openness
Blog
Press
Careers
Policies & Resources:
Privacy
User Agreement
Crisis
Contact Us

© 2005-2012 PatientsLikeMe. All Rights Reserved. Information on PatientsLikeMe.com does not constitute medical advice.
Information found on PatientsLikeMe is based on reports from PatientsLikeMe members.

Back to top
Please wait…